|
Cohance Lifesciences Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
17450.80 Cr.
|
P/BV
|
4.46
|
Book Value (Rs.)
|
102.24
|
|
52 Week High/Low (Rs.)
|
1121/267
|
FV/ML
|
1/1
|
P/E(X)
|
97.37
|
|
Bookclosure
|
09/08/2024
|
EPS (Rs.)
|
4.68
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| No. of Equity Shares (in Lacs) | 3826.00 | 2545.65 | 2545.65 | 2545.65 | 2545.65 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 38.26 | 25.46 | 25.46 | 25.46 | 25.46 |
| Total Share Capital | 38.26 | 25.46 | 25.46 | 25.46 | 25.46 |
| | | | | | |
| Reserves and Surplus | 3873.03 | 1671.12 | 2025.21 | 1709.73 | 1501.72 |
| Total Reserves and Surplus | 3873.03 | 1671.12 | 2025.21 | 1709.73 | 1501.72 |
| Total Shareholders Funds | 3911.29 | 1696.58 | 2050.66 | 1735.18 | 1527.18 |
| Minority Interest | 122.54 | 144.06 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 50.48 | 6.24 | 0.00 | 4.56 | 28.44 |
| Deferred Tax Liabilities [Net] | 97.90 | 90.98 | 64.79 | 58.23 | 54.32 |
| Other Long Term Liabilities | 901.10 | 728.44 | 21.24 | 0.70 | 0.46 |
| Long Term Provisions | 0.40 | 0.26 | 10.50 | 8.30 | 8.89 |
| Total Non-Current Liabilities | 1049.88 | 825.92 | 96.53 | 71.79 | 92.11 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 119.19 | 71.89 | 38.58 | 69.53 | 67.13 |
| Trade Payables | 284.58 | 80.21 | 42.36 | 65.16 | 105.90 |
| Other Current Liabilities | 194.87 | 195.22 | 21.22 | 20.13 | 33.19 |
| Short Term Provisions | 47.29 | 17.87 | 4.74 | 3.95 | 4.08 |
| Total Current Liabilities | 645.93 | 365.19 | 106.90 | 158.77 | 210.29 |
| | | | | | |
| Total Capital And Liabilities | 5729.64 | 3031.75 | 2254.09 | 1965.74 | 1829.59 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 1994.59 | 995.20 | 607.80 | 601.14 | 531.96 |
| Intangible Assets | 95.01 | 63.11 | 1.56 | 62.19 | 2.24 |
| Capital Work-In-Progress | 173.22 | 254.83 | 178.97 | 165.09 | 29.99 |
| Intangible Assets Under Development | 0.00 | 0.78 | 0.11 | 0.00 | 0.00 |
| Fixed Assets | 2262.82 | 1313.92 | 788.44 | 828.42 | 564.19 |
| Goodwill On Consolidation | 1283.65 | 655.11 | 60.26 | 0.00 | 0.00 |
| Non-Current Investments | 262.23 | 144.95 | 130.58 | 117.10 | 117.10 |
| Deferred Tax Assets [Net] | 2.64 | 0.55 | 0.00 | 0.00 | 0.00 |
| Long Term Loans And Advances | 1.28 | 4.55 | 0.01 | 0.02 | 0.07 |
| Other Non-Current Assets | 89.06 | 24.08 | 11.61 | 9.16 | 20.30 |
| Total Non-Current Assets | 3901.68 | 2143.16 | 990.90 | 954.70 | 701.66 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 266.32 | 191.74 | 773.90 | 418.94 | 481.22 |
| Inventories | 562.23 | 166.57 | 231.20 | 312.81 | 283.42 |
| Trade Receivables | 681.01 | 284.44 | 133.66 | 110.94 | 236.37 |
| Cash And Cash Equivalents | 59.66 | 88.67 | 50.50 | 68.01 | 47.31 |
| Short Term Loans And Advances | 7.97 | 0.39 | 0.83 | 0.19 | 0.19 |
| OtherCurrentAssets | 250.77 | 156.78 | 73.11 | 100.15 | 79.43 |
| Total Current Assets | 1827.96 | 888.59 | 1263.19 | 1011.05 | 1127.93 |
| | | | | | |
| Total Assets | 5729.64 | 3031.75 | 2254.09 | 1965.74 | 1829.59 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 48.41 | 58.55 | 40.43 | 29.38 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Unquoted Book Value | 0.00 | 144.95 | 130.58 | 117.10 | 117.10 |
| | | | | | |
| CURRENT INVESTMENTS | | | | | |
| Current Investments Quoted Market Value | 0.00 | 191.56 | 773.90 | 377.90 | 0.00 |
| Current Investments Unquoted Book Value | 0.00 | 0.18 | 0.00 | 41.03 | 481.22 |
